Produced by:
|
Hosted by:
|
Premier Media Sponsor:
|
Media Sponsors:
|
Home |
Register Now |
Conference at a Glance |
Workshop Agenda - 05/13 |
Conference Day 1 - 05/14 |
Conference Day 2 - 05/15 |
Sponsor & Exhibitor Info |
Accommodations |
Exhibitors |
Other Events
Conference Day One
Tuesday, May 14, 2002*
|
| 8:00am - 9:00am |
Registration
|
| 9:00am - 9:15am |
Welcome
|
| 9:15am - 10:00am |
Keynote I: IBM's Nanoscale Science/Technology Perspectives & Initiatives
Thomas N. Theis, Ph.D., Director, Physical Sciences, IBM Research Division, Thomas J. Watson Research Center
|
| 10:00am - 10:30am |
Morning Break/Exhibit Hall Opens
|
| For the remainder of the day, attendees may choose between three topics - Life Sciences, Nanoelectronics or Nanomaterials. Further information on each track is provided below. Switching between tracks throughout the course of the day is allowed.
|
Life Sciences Track
|
| The life sciences encompass a vast set of disciplines including biology, biochemistry, biotechnology, genetics, and multiple other specializations. This track of sessions examines the intersection of nanotechnology and life science. Near and long-term commercialization potential is explored in these sessions. Case study companies discuss their own business development strategies and also explain their products, markets and end-uses.
|
| 10:30am - 11:30am |
An Overview Of Nanotechnology Within The Life Sciences
This special opening session to the Life Sciences track provides a review of nanoscientific fundamentals within the formal life sciences. Additionally, the presenter also provides information on investors' perspectives regarding the transfer of life science into products including biotech and pharmaceutical devices.
Bryan Roberts, General Partner, Venrock Associates
|
| 11:30am - 12:45pm |
Case Study: Building A Business At The Intersection Of Nanotechnology & Life Sciences
Nanobiotech companies working toward drug discovery must address the normal business development processes of funding, IP protection, commercialization of research and more. Mr. Watson describes how Quantum Dot successfully met early challenges and continues to advance in the face of typical regulatory barriers and lengthy R&D processes.
Andy R. Watson, VP Business Development, Quantum Dot Corp.
|
| 12:45pm - 2:00pm |
Lunch Break/Visit Exhibit Hall
|
| 2:00pm - 3:00pm |
Proteins As The Key To Unlocking New Semiconductor Materials
This session focuses on the use of proteins to direct the nanostructure of semiconductors. Understanding and using the process by which nature makes materials in order to design new hybrid organic-inorganic materials is discussed.
Angela Belcher, Ph.D., Professor, University of Austin
|
| 3:00pm - 4:00pm |
Research Strategies And Prognostications In Nanotechnology In Europe
Come hear some of the leading scientists in Europe discuss their research
strategies and prognostications in Nanotechnology for the future. Dr. Christian Simm, Head of the Swiss Science and Technology Office in San Francisco will moderate a panel discussion with leading Swiss Scientist in the field of nanotechnolgoy, with focus on Nanofactory, Next Generation Cantilever and Nanotechnology Drug Delivery Systems.
Moderator:
Dr. Christian Simm, Swiss Science and Technology Office for Western USA and Western Canada
Panelists:
Prof. Hannes Bleuler, Prof. for Microengineering, Federal Institute of Technology Lausanne
Dr. Christoph Gerber, IBM Zurich Research Laboratory
Prof. Dr. Hans-Joachim Guentherodt, Head, Swiss National Center of Competence in Research in Nanoscience
Prof. Sotiris Pratsinis, Prof. for Process Engineering, Federal Institute of Technology Zurich
Prof. Horst Vogel, Director of the Laboratory for Chemical Physics and Polymer Membranes, Federal Institute of Technology Lausanne
|
| 4:00pm - 5:00pm |
Microfluidic Devices: Microarrays, The "Lab On A Chip"
Molecular diagnostics, the "lab on a chip" microfluidic devices that will be used to convert gene information into usable research and diagnostic data, are estimated to generate hundreds of millions of dollars in revenue in upcoming years. The first presenter in this session provides a basic understanding of these devices as well as structural characteristics and projected uses. The second set of presentations are from case study companies developing this unique market space.
Steve O'Connor, Founder, Nanostream Inc.
|
| 5:00pm - 6:30pm |
Networking Cocktail Reception
|
Nanoelectronics Track
|
| Modern civilization runs on a complex electronic infrastructure. This track of sessions first examines the scientific intersection of nanotechnology and electronics, including optics. Near and long-term commercialization potential is explored in these sessions. Case study companies discuss their business development strategies and also explain their products, markets and end-uses.
|
| 10:30am - 11:30am |
An Overview Of Nanotechnology Within Electronics
This session describes nanoelectronics, the science of creating smaller and faster computer chips and the systems that run on those chips. Specific technological applications of an industry projected to reach $433 billion by 2004 is discussed.
R. Stanley Williams, HP Labs Fellow & Director of Quantum Science Research
|
| 11:30am - 12:45pm |
Case Study: Building A Business At The Intersection Of Electronics & Nanotechnology
Early leaders in this sector have been successful in developing powerful intellectual property portfolios, attracted significant investment funding and assembled stellar management teams. A leading pioneer describes his firm's business development successes as well as projected long-term goals.
Larry Bock, President and CEO, Nanosys Inc.
|
| 12:45pm - 2:00pm |
Lunch Break/Visit Exhibit Hall
|
| 2:00pm - 3:00pm |
Self-Organization Of Nanoscaled Photonic Materials
Self-assembly is claimed to be an important avenue toward the manufacture of the next generation of nano-scaled molecular materials, especially for use in photonic devices. This session discusses the critical issues that must be considered for self-assembly strategy and will use self-assembly of porphyrinic arrays and clusters as illustration.
Charles Michael Drain, Department of Chemistry & Biochemistry, Hunter College of CUNY
|
| 3:00pm - 5:00pm |
Case Study Companies: Building Businesses At The Intersection Of Optics & Nano-Optics
Two companies focusing on the interaction of light and matter at the nano-level lead this informative two-part session. Each discusses its underlying science, the mission of their company and their companies' long-term business development strategy.
|
| |
(Part I) 3:00pm - 4:00pm
Commercial Applications Of Quantum Confined Atoms
A major breakthrough in modulating the properties of a single atom has been achieved by confining the atom in a nanocrystal. This Quantum Confined Atom (QCA) can be used to create, within a year to 5 years, novel products, which yield huge leaps in the performance of existing technology platforms. Near term applications in medical imaging, LED based lighting and magneto-optical memories are presented.
Dr. Rameshwar N. Bhargava, President, Nanocrystals Technology
Rajan Pillai, Director, Nanocrystals Technology
|
| |
(Part II) 4:00pm - 5:00pm
Vision Of New Physics & New Economics For Optical Communications
Nano-optics, or subwavelength optical elements that interact with light based on entirely new physical principles, allow optical processing to be done on a much smaller scale and perform new functions that bulk optics cannot. Mr. Weinbaum discusses his company's recent success in venture financing and also describes his firm's long-term business strategy.
Barry J. Weinbaum, CEO and President, NanoOpto Corporation
|
| 5:00pm - 6:30pm |
Networking Cocktail Reception
|
Nanomaterials Track
|
| The Materials Sciences furnish the building blocks of modern manufacturing. Nanomaterials are materials whose microstructural building blocks have been precision engineered to fall below 250 nanometers, preferably sub-100, on the nanometer scale. This track of sessions examines the intersection of nanotechnology and materials sciences. Near and long-term commercialization potential are also explored in these sessions. Case study companies discuss their business development strategies and also explain their products, markets and end-uses.
|
| 10:30am - 11:30am |
An Overview Of Nanotechnology Within The Materials Sciences
This session covers advances in the materials of nanotechnology such as nanoparticles, nanowires and everything in between. Over the last few years, we have begun to see a transition from "nanoscience," the science of nanometer-sized materials, toward "nanotechnology," the multi-disciplinary integration of nanomaterials with other sciences such as biology, chemistry, electronics and optics. This transition has resulted from extraordinary advances in the synthesis of nanomaterials and the increasing ability to interface those materials with the macroscopic world. This overview presents specific recent advances in the materials of nanoscience rocketing us toward the future of nanotechnology.
Stephen Empedocles, Ph.D., Director, Business Development, Nanosys, Inc.
|
| 11:30am - 12:45pm |
Case Study: Early-Stage Companies Developing "Passive" Nanomaterials
Nanotechnology is largely an early-stage sector. A number of startups in the passive nanomaterials sector are successfully growing their businesses by: moving research into the product mode, strategic partnering, attracting investors and utilizing other early-stage business strategies. This session's speaker provides an experienced look at "what works" and also provide a deeper look into the case study company and the evolution of its market niche.
Harris A. Goldberg, President, InMat LLC
|
| 12:45pm - 2:00pm |
Lunch Break/Visit Exhibit Hall
|
| 2:00pm - 3:00pm |
Case Study: Publicly Traded Nanomaterials Companies
A number of passive nanomaterials companies have been in business for several years and have already grown their business from research foundations into successful. This presentation provides valuable insights into a pioneer's success.
Panelists
Isaiah W. Cox, President, Cool Chips PLC
Dr. William P. Long, President & Director, Altair International Inc.
|
| 3:00pm - 5:00pm |
Small Technology/Big Finance: Straight Talk On Private Investment In Nanotechnology
With the National Science Foundation predicting the domestic market for nanotechnology products and services will reach $1.0 trillion by 2015, VCs are paying full attention to emerging companies in this field. As a result, it is expected that $1.0 billion in venture capital financing will be allocated to nanotechnology over the next two years. In this panel session, leading venture capitalists discuss the state of the nanotechnology market, the potential for venture financing, alternative methods of funding and their ROI expectations for this burgeoning field.
Moderator
Victor H. Boyajian, Chair, Sills Cummis Capital Markets Group and Corporate Technology Practice
Panelists
Kevin Lalande, Sr. Associate, Austin Ventures
Alan Marty, Executive-in-Residence, JPMorgan Partners
Warren Packard, Managing Director, Draper Fisher Jurvetson
Bryan Roberts, General Partner, Venrock Associates
Benjamin Savage, Associate, Wasserstein Ventures
|
| 5:00pm - 6:30pm |
Networking Cocktail Reception
|
|
